Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Jazz Pharmaceuticals plcJAZZ · Entity 818 | Director | August 07, 2025 | August 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Jazz Pharmaceuticals plc
Report date August 07, 2025 · Filed August 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 16,500 |
Ending reported balance
After 2025-08-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-08-07 · Grant · Acquired 3,507 · Balance 18,305 F1: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026. Row 2 · 2025-08-08 · Tax withholding · Disposed 1,805 · Balance 16,500 F2: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026.
F2: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 08, 2025 Filed Aug 11, 2025 21:39 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 1,805 | $111.25 | $200,805.17 |
DisclosureSEC source: 0001765581-25-000084 · edgardoc.xml · nonDerivative · entry 2 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 07, 2025 Filed Aug 11, 2025 21:39 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 3,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000084 · edgardoc.xml · nonDerivative · entry 1 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,305 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026. Read SEC document |
| August 06, 2024 Filed Aug 6, 2024 22:40 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 1,484 | $111.35 | $165,243.40 |
DisclosureSEC source: 0001765581-24-000076 · edgardoc.xml · nonDerivative · entry 2 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,798 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:40 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 3,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-24-000076 · edgardoc.xml · nonDerivative · entry 1 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,282 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025. Read SEC document |
| August 14, 2023 Filed Aug 15, 2023 23:51 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 1,241 | $138.16 | $171,454.08 |
DisclosureSEC source: 0001765581-23-000098 · edgardoc.xml · nonDerivative · entry 2 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,551 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. F3 · price: Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $137.67 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 23:51 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 3,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-23-000098 · edgardoc.xml · nonDerivative · entry 1 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,792 F1 · kind: Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 22:36 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 1,089 | $152.32 | $165,876.92 |
DisclosureSEC source: 0001765581-22-000094 · edgardoc.xml · nonDerivative · entry 2 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,717 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 22:36 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 2,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-22-000094 · edgardoc.xml · nonDerivative · entry 1 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,806 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:45 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 9 | $150.49 | $1,354.41 |
DisclosureSEC source: 0001765581-22-000051 · edgardoc.xml · nonDerivative · entry 2 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,245 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:45 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 457 | $148.92 | $68,056.44 |
DisclosureSEC source: 0001765581-22-000051 · edgardoc.xml · nonDerivative · entry 1 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,254 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| July 29, 2021 Filed Aug 2, 2021 22:23 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-21-000079 · edgardoc.xml · nonDerivative · entry 1 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,711 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 29, 2022. Read SEC document |
| August 06, 2020 Filed Aug 11, 2020 00:05 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 6,765 | $0.00 Strike: $127.07 | $0.00 |
DisclosureSEC source: 0001765581-20-000087 · edgardoc.xml · derivative · entry 2 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,765 Underlying: Ordinary Shares · 6,765 shares Expires 2030-08-05 F2 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in full on July 30, 2021. Read SEC document |
| August 06, 2020 Filed Aug 11, 2020 00:05 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 2,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-20-000087 · edgardoc.xml · nonDerivative · entry 1 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,465 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2021. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 21:31 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,805 | $0.00 Strike: $137.12 | $0.00 |
DisclosureSEC source: 0001765581-19-000072 · edgardoc.xml · derivative · entry 2 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,805 Underlying: Ordinary Shares · 4,805 shares Expires 2029-08-07 F2 · kind: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019. F2 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 21:31 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 1,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-19-000072 · edgardoc.xml · nonDerivative · entry 1 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,760 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 1, 2020. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 00:51 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 7,100 | $0.00 Strike: $140.03 | $0.00 |
DisclosureSEC source: 0001765581-19-000031 · edgardoc.xml · derivative · entry 2 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,100 Underlying: Ordinary Shares · 7,100 shares Expires 2029-02-27 F2 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest 1/3 on February 14, 2020 and in 24 equal monthly installments thereafter. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 00:51 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 2,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-19-000031 · edgardoc.xml · nonDerivative · entry 1 ORiordan Anne · CIK 0001767870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,840 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in equal annual installments over three years measured from the vesting commencement date of February 14, 2019, with 1/3 vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent two years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.